Literature DB >> 17785543

Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method.

William Pao, Marc Ladanyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17785543     DOI： 10.1158/1078-0432.CCR-07-1387

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  67 in total

1.  A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development.

Authors:  Binsheng Zhao; Geoffrey R Oxnard; Chaya S Moskowitz; Mark G Kris; William Pao; Pingzhen Guo; Valerie M Rusch; Marc Ladanyi; Naiyer A Rizvi; Lawrence H Schwartz
Journal:  Clin Cancer Res       Date:  2010-06-09       Impact factor: 12.531

2.  ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens.

Authors:  Jinguo Liu; Ruiying Zhao; Jie Zhang; Jian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

Review 3.  [Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing].

Authors:  A Warth; L Bubendorf; S Gütz; A Morresi-Hauf; M Hummel; K Junker; U Lehmann; I Petersen; P A Schnabel
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

4.  KRAS mutations: an old oncogene becomes a new predictive biomarker.

Authors:  Gregory J Riely; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

5.  The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer.

Authors:  Jingya Zhao; Xiaoying Wang; Liang Xue; Nuo Xu; Xin Ye; Haiying Zeng; Shaohua Lu; Jie Huang; Sujie Akesu; Chen Xu; Deming He; Yunshan Tan; Qunying Hong; Qun Wang; Guanshan Zhu; Yingyong Hou; Xin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-22       Impact factor: 4.553

6.  Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.

Authors:  Lucheng Zhu; Shirong Zhang; Yanping Xun; Yanping Jiang; Bing Xia; Xueqin Chen; Limin Wang; Hong Jiang; Shenglin Ma
Journal:  Pathol Oncol Res       Date:  2017-09-03       Impact factor: 3.201

7.  [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].

Authors:  Jing Zhao; Jinyin Zhao; Xiao Zhao; Weijun Chen; Wei Zhong; Li Zhang; Longyun Li; Mengzhao Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-01

8.  Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.

Authors:  Yan Liu; Bing-Quan Wu; Hao-Hao Zhong; Pei Hui; Wei-Gang Fang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

9.  Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients.

Authors:  Hee Joung Kim; Seo Young Oh; Wan Seop Kim; Sun Jong Kim; Gwang Ha Yoo; Won Dong Kim; Kye Young Lee
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

Review 10.  Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Authors:  Frank S Ong; Kingshuk Das; Jay Wang; Hana Vakil; Jane Z Kuo; Wendell-Lamar B Blackwell; Stephen W Lim; Mark O Goodarzi; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.